Emtricitabine Recruiting Phase 4 Trials for Bone Loss Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03916328BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study